Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Wysocki

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 2, 2009
Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertensionJan Wysocki, Minghao Ye, Eva Rodriguez, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 5, 2017
Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin IIChristoph Maier, Ines Schadock, Philipp K Haber, et al.
Journal of the American Society of Nephrology : JASN|March 3, 2022
A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 InfectionLuise Hassler, Jan Wysocki, Ian Gelarden, et al.
Iscience|August 23, 2024
Activation of limbal epithelial proliferation is partly controlled by the ACE2-LCN2 pathwayHuimin Jiang, Min Liu, Wending Yang, et al.
Plos One|April 25, 2024
Effect of SARS-CoV-2 S protein on the proteolytic cleavage of the epithelial Na+ channel ENaCGermán Ricardo Magaña-Ávila, Erika Moreno, Consuelo Plata, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2022
Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Life Science Alliance|April 11, 2023
Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Clinical Genitourinary Cancer|March 19, 2018
Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted AgentsAntoine Angelergues, Eleni Efstathiou, Revekka Gyftaki, et al.
Nature Communications|September 26, 2025
Physiologic Homeostasis in a Living Human after Pig Kidney XenotransplantationSul A Lee, Marie-Camille Lafargue, Winfred W Williams, et al.
Cell|December 5, 2025
Renal PIEZO2 is an essential regulator of reninRose Z Hill, Jonathan W Nelson, Georgina Gyarmati, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Hypertension (Dallas, Tex. : 1979)|December 2, 2009
Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertensionJan Wysocki, Minghao Ye, Eva Rodriguez, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 5, 2017
Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin IIChristoph Maier, Ines Schadock, Philipp K Haber, et al.
Journal of the American Society of Nephrology : JASN|March 3, 2022
A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 InfectionLuise Hassler, Jan Wysocki, Ian Gelarden, et al.
Iscience|August 23, 2024
Activation of limbal epithelial proliferation is partly controlled by the ACE2-LCN2 pathwayHuimin Jiang, Min Liu, Wending Yang, et al.
Plos One|April 25, 2024
Effect of SARS-CoV-2 S protein on the proteolytic cleavage of the epithelial Na+ channel ENaCGermán Ricardo Magaña-Ávila, Erika Moreno, Consuelo Plata, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2022
Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Life Science Alliance|April 11, 2023
Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Clinical Genitourinary Cancer|March 19, 2018
Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted AgentsAntoine Angelergues, Eleni Efstathiou, Revekka Gyftaki, et al.
Nature Communications|September 26, 2025
Physiologic Homeostasis in a Living Human after Pig Kidney XenotransplantationSul A Lee, Marie-Camille Lafargue, Winfred W Williams, et al.
Cell|December 5, 2025
Renal PIEZO2 is an essential regulator of reninRose Z Hill, Jonathan W Nelson, Georgina Gyarmati, et al.
Pageof 8